Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocol

Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocol

Introduction Iron deficiency anaemia (IDA) is the most common systemic manifestation of inflammatory bowel disease (IBD) that has detrimental effects on quality of life (QoL) and disease outcomes. Iron deficiency (ID), with or without anaemia, poses a diagnostic and therapeutic challenge in patients...

Full description

Bibliographic Details
Main Authors: Andrea E van der Meulen-de Jong, Gerard Dijkstra, Zlatan Mujagic, Marjolijn Duijvestein, Rogier L Goetgebuer, Roberta Loveikyte
Format: Article
Language:English
Published: BMJ Publishing Group 2024-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/1/e077511.full

Internet

https://bmjopen.bmj.com/content/14/1/e077511.full

Similar Items